Vivanza Biosciences Balance Sheet Annual

BSE: 530057 | NSE: - | ISIN: INE984E01035 | Sector: Biotechnology & Drugs

4.09 +0.06 (1.49%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	0.17	0.14	0.06	-3.09
Cashand Short Term Investments	0.17	0.14	0.06	-3.09
Accounts Receivable- Trade Net	11.54	12.48	7.84	6.25
Total Receivables Net	13.16	16.61	9.77	7.31
Total Inventory	2.01	2.47	2.43	0.65
Other Current Assets Total	0.41	0.33	0.20	0.15
Total Current Assets	15.74	19.55	12.45	5.01
Property/ Plant/ Equipment Total- Net	0.70	0.68	0.68	0.69
Intangibles Net	1.64	0.03	0.03	0.03
Long Term Investments	0.00	0.60	0.60	1.11
Note Receivable- Long Term	0.82	0.01	0.20	-
Other Long Term Assets Total	0.60	0.00	0.00	0.00
Total Assets	19.50	22.48	15.56	8.45
Accounts Payable	8.23	9.55	5.48	3.86
Current Portof LT Debt/ Capital Leases	2.49	3.28	0.18	-
Other Currentliabilities Total	1.46	0.84	1.08	1.07
Total Current Liabilities	12.18	16.95	9.47	5.29
Long Term Debt	2.68	1.43	2.60	0.00
Total Long Term Debt	2.68	1.43	2.60	0.00
Total Debt	5.17	8.00	5.51	0.36
Deferred Income Tax	0.00	0.00	0.00	0.00
Other Liabilities Total	0.00	0.00	-	0.00
Total Liabilities	14.86	18.39	12.07	5.29
Common Stock Total	4.00	4.00	4.00	4.00
Retained Earnings( Accumulated Deficit)	0.64	0.09	-0.51	-0.84
Total Equity	4.64	4.09	3.49	3.16
Total Liabilities Shareholders' Equity	19.50	22.48	15.56	8.45
Total Common Shares Outstanding	4.00	4.00	4.00	4.00
Tangible Book Valueper Share Common Eq	0.75	0.61	0.46	0.38
Goodwill Net	-	1.61	1.61	1.61
Notes Payable/ Short Term Debt	-	3.29	2.74	0.36